RELEVANT-C study: Patient-reported prevalence of lower extremity lymphedema after sentinel lymph node mapping vs lymphadenectomy after surgery for early-stage cervical cancer Journal Article


Authors: Miller, K. M.; Liu, C.; Zhou, Q.; Iasonos, A.; Baser, R.; Ramesh, B.; Sonoda, Y.; Mueller, J. J.; Broach, V.; Abu-Rustum, N. R.; Leitao, M. M. Jr
Article Title: RELEVANT-C study: Patient-reported prevalence of lower extremity lymphedema after sentinel lymph node mapping vs lymphadenectomy after surgery for early-stage cervical cancer
Abstract: Objective: To compare the prevalence of patient-reported lower extremity lymphedema and evaluate patient-reported quality of life after sentinel lymph node mapping vs comprehensive lymphadenectomy with or without sentinel lymph node mapping for the surgical management of early-stage cervical cancer. Methods: In July 2022, we mailed a survey that included a validated 13-item lower extremity lymphedema screening questionnaire to patients who underwent lymph node evaluation at the time of primary surgery for the 2018 International Federation of Gynecology and Obstetrics stage IA1 to IIB cervical cancer between January 1, 2006, and January 31, 2019. We excluded patients diagnosed with lower extremity lymphedema prior to surgery and those who answered ≤6 survey items, and we carried out 2 group comparisons: sentinel lymph node mapping vs lymphadenectomy with or without sentinel lymph node mapping, and patients with lower extremity lymphedema vs patients without. Results: Of 459 potential participants, 90 (20%) responded to the survey, all of which were evaluable (37 sentinel lymph nodes; 53 lymphadenectomies ± sentinel lymph nodes). Self-reported lower extremity lymphedema prevalence was 10.8% (4/37) in the sentinel lymph node mapping group and 43.4% (23/53) in the lymphadenectomy with or without sentinel lymph node mapping group (OR 6.32, 95% CI 2.14 to 23.5, p = .002). Histologic subtype and number of lymph nodes removed were associated with increased prevalence of lower extremity lymphedema. After adjusting for the histology subtype, lymphadenectomy retained independent association with an increased prevalence of lower extremity lymphedema over sentinel lymph node mapping (OR 4.96, 95% CI 1.61 to 18.8, p = .009). Patients with self-reported lower extremity lymphedema had significantly worse quality of life compared to those without self-reported lower extremity lymphedema. Conclusions: We found sentinel lymph node mapping to be independently associated with a significantly decreased prevalence of patient-reported lower extremity lymphedema and with improved quality of life in patients undergoing surgical management of early-stage cervical cancer. © 2024 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society
Keywords: adult; controlled study; major clinical study; histopathology; cancer staging; lymph node dissection; sentinel lymph node; lymphadenectomy; quality of life; prevalence; cohort analysis; cancer screening; retrospective study; lymphedema; questionnaire; uterine cervix cancer; cross-sectional study; patient-reported outcomes; cervical cancer; patient-reported outcome; human; female; article; lower limb
Journal Title: International Journal of Gynecological Cancer
Volume: 35
Issue: 2
ISSN: 1048-891X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2025-02-01
Start Page: 100063
Language: English
DOI: 10.1016/j.ijgc.2024.100063
PROVIDER: scopus
PUBMED: 39971445
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Mario M. Leitao Jr -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Raymond E Baser
    133 Baser
  2. Yukio Sonoda
    472 Sonoda
  3. Mario Leitao
    575 Leitao
  4. Qin Zhou
    254 Zhou
  5. Alexia Elia Iasonos
    363 Iasonos
  6. Jennifer Jean Mueller
    186 Mueller
  7. Vance Andrew Broach
    115 Broach
  8. Bhavani Ramesh
    6 Ramesh
  9. Kathryn Miller
    21 Miller